Orpea S.A. (ORRRY) Aktienanalyse
Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Orpea S.A. (ORRRY) ist im Healthcare-Sektor taetig, zuletzt notiert bei $ mit einer Marktkapitalisierung von 0. Bewertet mit 45/100 (vorsichtig) bei Wachstumspotenzial, finanzieller Gesundheit und Momentum.
Zuletzt analysiert: 17. März 2026Orpea S.A. (ORRRY) Gesundheitswesen & Pipeline-Uebersicht
Orpea S.A., a global healthcare provider based in France, operates nursing homes, assisted-living facilities, and rehabilitation hospitals. With a focus on elderly care and rehabilitation services across multiple countries, Orpea faces challenges in a competitive and regulated healthcare landscape while navigating financial performance issues reflected in its negative profit margin.
Investmentthese
Orpea S.A. presents a complex investment case. The company's global presence in the growing elderly care market offers long-term potential, driven by demographic trends and increasing demand for specialized care facilities. However, Orpea's negative profit margin of -5.1% and negative P/E ratio of -4.62 raise concerns about its financial performance. The company's beta of 0.76 suggests lower volatility compared to the market. Successful execution of its restructuring plans and improved operational efficiency are critical for restoring profitability and investor confidence. Monitoring key metrics such as occupancy rates, cost management, and regulatory compliance is essential for assessing Orpea's investment viability.
Basierend auf FMP-Finanzdaten und quantitativer Analyse
Wichtige Highlights
- Market capitalization of $0.37 billion reflects investor valuation of Orpea S.A.
- Negative P/E ratio of -4.62 indicates current unprofitability.
- Profit margin of -5.1% highlights challenges in achieving profitability.
- Gross margin of 2.2% suggests limited pricing power or high cost of services.
- Beta of 0.76 indicates lower volatility compared to the overall market.
Wettbewerber & Vergleichsunternehmen
Staerken
- Global presence and diversified operations.
- Comprehensive range of healthcare services.
- Experienced management team.
- Established relationships with payers.
Schwaechen
- Negative profit margin.
- High debt levels.
- Exposure to regulatory risks.
- Reputational risks.
Katalysatoren
- Ongoing: Implementation of restructuring plans to improve financial performance.
- Ongoing: Expansion of specialized care services to attract a higher paying customer base.
- Upcoming: Potential acquisitions of smaller care facilities to expand geographic footprint.
- Ongoing: Technological innovation to improve efficiency and quality of services.
- Ongoing: Expansion of home care services to cater to the growing demand for in-home care.
Risiken
- Ongoing: Negative profit margin and high debt levels.
- Potential: Changes in government regulations and reimbursement models.
- Potential: Increasing competition from other healthcare providers.
- Potential: Economic downturns affecting demand for services.
- Ongoing: Reputational risks associated with quality of care and ethical practices.
Wachstumschancen
- Expansion into emerging markets: Orpea can capitalize on the growing demand for elderly care services in emerging markets such as Brazil, Russia, and China. These markets offer significant growth potential due to their large populations and increasing healthcare spending. Successful entry and adaptation to local regulations and cultural nuances are crucial for success. This expansion could contribute significantly to revenue growth over the next 5-10 years.
- Development of specialized care services: Orpea can enhance its service offerings by developing specialized care programs for specific conditions such as dementia, Alzheimer's disease, and Parkinson's disease. These specialized programs can attract a higher paying customer base and differentiate Orpea from its competitors. The market for specialized care services is expected to grow significantly in the coming years, driven by the increasing prevalence of these conditions. Timeline for implementation is 2-3 years.
- Strategic acquisitions: Orpea can pursue strategic acquisitions of smaller care facilities and regional operators to expand its geographic footprint and market share. Acquisitions can provide access to new markets, technologies, and talent. Careful due diligence and integration are essential for realizing the full benefits of acquisitions. This strategy could yield significant growth within 3-5 years.
- Technological innovation: Orpea can invest in technological innovation to improve the efficiency and quality of its services. This includes implementing electronic health records, telemedicine solutions, and remote monitoring devices. Technology can help to reduce costs, improve patient outcomes, and enhance the overall care experience. Implementation of these technologies can begin immediately and show results within 1-2 years.
- Enhanced home care services: Orpea can expand its home care services to cater to the growing demand for in-home care. Home care services offer a more affordable and convenient alternative to facility-based care for many elderly individuals. Orpea can leverage its existing infrastructure and expertise to provide high-quality home care services. This expansion can be implemented within the next year and contribute to revenue growth over the long term.
Chancen
- Expansion into emerging markets.
- Development of specialized care services.
- Strategic acquisitions.
- Technological innovation.
Risiken
- Increasing competition.
- Changes in government regulations.
- Economic downturns.
- Labor shortages.
Wettbewerbsvorteile
- Established brand reputation in the healthcare industry.
- Extensive network of facilities across multiple countries.
- Specialized expertise in elderly care and rehabilitation services.
- Long-term relationships with insurance companies and government programs.
Ueber ORRRY
Founded in 1989, Orpea S.A. has grown into a multinational healthcare provider specializing in long-term care and rehabilitation services. Headquartered in Puteaux, France, the company operates a network of nursing homes, assisted-living facilities, post-acute and rehabilitation hospitals, and psychiatric hospitals across Europe, Latin America, and Asia. Orpea's facilities provide a comprehensive range of services, including accommodation, meals, personalized support, and specialized medical care for elderly and dependent individuals. The company's post-acute and rehabilitation hospitals offer services for various conditions, including geriatrics, musculoskeletal, nervous system, and cardiovascular issues. Its psychiatric hospitals cater to patients with mood disorders, anxiety disorders, and other mental health conditions. In addition to facility-based care, Orpea also offers home care services, including housekeeping, daily life assistance, and movement assistance. With operations in over 20 countries, Orpea has established a significant presence in the global healthcare market, employing approximately 76,000 people.
Was das Unternehmen tut
- Operates nursing homes providing personalized support services.
- Manages assisted-living facilities for elderly individuals.
- Runs post-acute and rehabilitation hospitals for various medical conditions.
- Offers psychiatric hospital services for patients with mental health disorders.
- Provides home care services including housekeeping and daily life assistance.
- Offers accommodation, meals, and laundry services in its facilities.
- Organizes daily events, entertainment, and therapeutic workshops for residents.
Geschaeftsmodell
- Generates revenue from accommodation and care services provided in its facilities.
- Receives payments from residents, insurance companies, and government programs.
- Offers a range of services including medical care, rehabilitation, and assisted living.
- Expands its network through acquisitions and development of new facilities.
Branchenkontext
Orpea S.A. operates within the medical care facilities industry, which is experiencing growth due to the aging global population and increasing demand for long-term care services. The industry is characterized by a mix of public and private providers, with varying levels of regulation and reimbursement models. Key competitors include BTMD (BioTelemetry Inc.), CSSPF (Care Solutions Holding SA), DFHL (Dahongli Investment Holding Co Ltd), GUERF (Guerbet SA), and HYBT (Hybertone Corporation). Orpea's success depends on its ability to provide high-quality care, manage costs effectively, and navigate the complex regulatory landscape in each of its operating countries. The industry is also facing increasing scrutiny regarding quality of care and ethical practices.
Wichtige Kunden
- Elderly individuals requiring long-term care.
- Patients needing post-acute and rehabilitation services.
- Individuals with mental health disorders seeking psychiatric care.
- Families seeking care solutions for their loved ones.
Finanzdaten
Chart & Info
Orpea S.A. (ORRRY) Aktienkurs: Price data unavailable
Aktuelle Nachrichten
Keine aktuellen Nachrichten fuer ORRRY verfuegbar.
Analystenkonsens
Konsens-Bewertung
Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer ORRRY.
Kursziele
Wall-Street-Kurszielanalyse fuer ORRRY.
MoonshotScore
Was bedeutet diese Bewertung?
Der MoonshotScore bewertet das Wachstumspotenzial von ORRRY auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.
Wettbewerber & Vergleichsunternehmen
Fuehrung: Laurent Guillot
CEO
Laurent Guillot is the CEO of Orpea S.A. His background includes extensive experience in managing large organizations and driving strategic growth. Prior to joining Orpea, he held leadership positions in various multinational companies, focusing on operational efficiency and business development. He is known for his expertise in navigating complex regulatory environments and implementing successful turnaround strategies. His educational background includes advanced degrees in business administration and engineering.
Erfolgsbilanz: Since assuming the role of CEO, Laurent Guillot has focused on restructuring Orpea's operations and restoring investor confidence. Key initiatives include implementing cost-saving measures, improving quality of care, and strengthening relationships with regulatory authorities. He has also overseen the development of new strategic partnerships and the expansion of Orpea's services in key markets. His leadership is aimed at driving sustainable growth and enhancing shareholder value.
Orpea S.A. ADR-Informationen Nicht gesponsert
An American Depositary Receipt (ADR) is a certificate representing shares of a foreign company that trades on U.S. stock exchanges. ORRRY, as an ADR, allows U.S. investors to invest in Orpea S.A. without the complexities of cross-border transactions. The ADR is denominated in U.S. dollars, simplifying trading and reporting for U.S. investors. The underlying shares are held by a custodian bank in the home country, France.
- Heimatmarkt-Ticker: Euronext Paris, France
- ADR-Stufe: 1
- ADR-Verhaeltnis: 1:1
- Heimatmarkt-Ticker: ORRR
ORRRY OTC-Marktinformationen
The OTC Other tier represents the lowest tier of the over-the-counter (OTC) market. Companies in this tier often have limited financial disclosure and may not meet the listing requirements of major exchanges like the NYSE or NASDAQ. Investing in OTC Other stocks carries higher risks due to the potential for limited liquidity, price volatility, and lack of regulatory oversight compared to exchange-listed stocks. Investors should exercise caution and conduct thorough due diligence before investing in ORRRY.
- OTC-Stufe: OTC Other
- Offenlegungsstatus: Unknown
- Limited financial disclosure.
- Potential for price manipulation.
- Higher risk of fraud.
- Lower liquidity.
- Lack of regulatory oversight.
- Verify the company's registration and legal status.
- Obtain and review available financial statements.
- Assess the company's management team and track record.
- Research the company's industry and competitive landscape.
- Evaluate the company's risk factors.
- Understand the OTC market and its associated risks.
- Consult with a qualified financial advisor.
- Positive news coverage and media mentions.
- Partnerships with reputable organizations.
- Active engagement with investors and stakeholders.
- Clear and transparent communication.
- Compliance with applicable laws and regulations.
ORRRY Healthcare Aktien-FAQ
What are the key factors to evaluate for ORRRY?
Orpea S.A. (ORRRY) currently holds an AI score of 45/100, indicating low score. Key strength: Global presence and diversified operations.. Primary risk to monitor: Ongoing: Negative profit margin and high debt levels.. This is not financial advice.
How frequently does ORRRY data refresh on this page?
ORRRY prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven ORRRY's recent stock price performance?
Recent price movement in Orpea S.A. (ORRRY) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Global presence and diversified operations.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider ORRRY overvalued or undervalued right now?
Determining whether Orpea S.A. (ORRRY) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying ORRRY?
Before investing in Orpea S.A. (ORRRY), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding ORRRY to a portfolio?
Potential reasons to consider Orpea S.A. (ORRRY) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Global presence and diversified operations.. Additionally: Comprehensive range of healthcare services.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.
Can I buy fractional shares of ORRRY?
Yes, most major brokerages offer fractional shares of Orpea S.A. (ORRRY) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track ORRRY's earnings and financial reports?
Orpea S.A. (ORRRY) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for ORRRY earnings announcements is recommended.
Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.
Offizielle Ressourcen
Daten dienen ausschliesslich zu Informationszwecken.
- Financial data may be outdated or incomplete.
- AI analysis is pending and may provide additional insights.
- OTC market investments carry higher risks.